TMED ranks 2nd and UTES 5th of 35 funds in the US Active Sector Category.
TMED vs UTES
0.0%by weight
TMED −0.05pt a year
0.44%0.49%
UTES 21.3×the volume
7.43K158K
TMED vs UTES Performance
+20.6%−6.8%
- TMED 0.44%, better
- UTES 0.49%
- TMED $34M
- UTES $1.17B
- TMED +20.6%, better
- UTES −6.8%
- TMED
- UTES 1.60%
- TMED 112
- UTES 19
- TMED 7.43K sh
- UTES 158K sh, better
- TMED $34.31
- UTES $76.69
ETF.net Grade
| Pillar | TMED | UTES |
|---|---|---|
| Cost | A82Higher | A79 |
| Mission | ||
| Risk | B55Higher | D29 |
| Tradability | B59 | A90Higher |
| Holdings | A91Higher | D39 |
| Durability | D35 | A85Higher |
Rank among US Active Sector funds
Same Category. TMED and UTES are both graded against the same 35 US Active Sector funds, so their Grades compare head to head.
Our read on each fund
TMEDB
UTESB
In short
UTES Utilities, but stock-picked. UTES has run an active, value-driven, bottom-up portfolio of electricity, gas and water companies since 2015, at a fee below what the typical active US equity ETF charges.
Stated mandate
UTES The Fund seeks total return from capital appreciation and income.
Why people hold it
Worth knowing
TMED vs UTES Holdings
How TMED and UTES differ
0.0%
Shared holdings make up 0.0% of TMED and 0.0% of UTES.
Level by level
- Asset class0.0%
- Sector0.0%
- Holdings0.0%
- Country96.1%
Sector
| Sector | More in TMEDMore in UTES | TMED | UTES |
|---|---|---|---|
| Utilities | UTES +100.0 points | 0.0% | 100.0% |
| Health Care | TMED +99.9 points | 99.9% | 0.0% |
| Technology | TMED +0.1 points | 0.1% | 0.0% |
Country, concentration and asset class
Country
| Country | More in TMEDMore in UTES | TMED | UTES |
|---|---|---|---|
| United States | UTES +3.9 points | 96.1% | 100.0% |
| Switzerland | TMED +1.8 points | 1.8% | 0.0% |
| Germany | TMED +0.7 points | 0.7% | 0.0% |
| Canada | TMED +0.6 points | 0.6% | 0.0% |
| Other countries (3) | TMED +0.8 points | 0.8% | 0.0% |
Concentration
- TMED37.0%
- UTES70.5%
- TMED110
- UTES18
Asset class
- TMED
- Equity
- UTES
- Alternatives
Holdings
- Only in TMED110
- In both0
- Only in UTES18
Only in TMED
110 securities, 97.1% of TMED by weight
- Eli Lilly & Co Common Stock5.94%
- UnitedHealth Group Inc Common Stock USD.015.20%
- Alnylam Pharmaceuticals Inc Common Stock USD.013.89%
- Insulet Corp Common Stock USD.0013.80%
- Thermo Fisher Scientific Inc Common Stock USD1.03.42%
- Gilead Sciences Inc Common Stock USD.0013.09%
- Agilent Technologies Inc Common Stock USD.013.08%
- Intuitive Surgical Inc Common Stock USD.0013.00%
- Elanco Animal Health Inc Common Stock2.74%
- Danaher Corp Common Stock USD.012.46%
- Cencora Inc Common Stock USD.012.40%
- Ascendis Pharma A/S Common Stock DKK1.02.37%
- West Pharmaceutical Services Common Stock USD.252.31%
- Cytokinetics Inc Common Stock USD.0012.24%
- Waters Corp Common Stock USD.012.17%
- Vaxcyte Inc Common Stock USD.0012.09%
- Dexcom Inc Common Stock USD.0012.05%
- Denali Therapeutics Inc Common Stock USD.011.75%
- Dyne Therapeutics Inc Common Stock USD.00011.72%
- Moonlake Immunotherapeutics Common Stock USD.00011.70%
- Boston Scientific Corp Common Stock USD.011.64%
- Cabaletta Bio Inc Common Stock USD.000011.62%
- Shattuck Labs Inc Common Stock USD.00011.58%
- Idexx Laboratories Inc Common Stock USD.11.51%
- Abbott Laboratories Common Stock1.51%
- Biogen Inc Common Stock USD.00051.38%
- Immunome Inc Common Stock USD.00011.28%
- Mckesson Corp Common Stock USD.011.23%
- Humana Inc Common Stock USD.16666661.04%
- Adaptive Biotechnologies Common Stock USD.00011.01%
- Prime Medicine Inc Common Stock USD.000010.98%
- Oruka Therapeutics Inc Common Stock USD.0010.96%
- Revvity Inc Common Stock USD1.00.90%
- Onkure Therapeutics Inc A Common Stock USD.00010.81%
- Cvs Health Corp Common Stock USD.010.80%
- Erasca Inc Common Stock USD.00010.80%
- Repligen Corp Common Stock USD.010.78%
- Cg Oncology Inc Common Stock0.76%
- Ionis Pharmaceuticals Inc Common Stock USD.0010.75%
- Immatics NV Common Stock0.74%
- Biontech SE Adr Adr0.72%
- Freenome Inc Common Stock USD.00010.71%
- Sartorius AG Common Stock0.67%
- Billiontoone Inc Class A Common Stock USD.000010.64%
- Dianthus Therapeutics Inc Common Stock USD.0010.63%
- Xenon Pharmaceuticals Inc Common Stock0.59%
- Disc Medicine Inc Common Stock USD.00010.52%
- Kailera Therapeutics Inc Common Stock USD.000010.47%
- Kardigan Inc Common Stock USD.000010.45%
- Corvus Pharmaceuticals Inc Common Stock USD.00010.41%
Only in UTES
18 securities, 99.6% of UTES by weight
- Constellation Energy Corp11.41%
- Talen Energy Corp11.39%
- Vistra Corp9.63%
- Xcel Energy Inc7.27%
- CenterPoint Energy Inc6.78%
- American Electric Power Co Inc4.85%
- Entergy Corp4.85%
- NiSource Inc4.84%
- Alliant Energy Corp4.79%
- IDACORP Inc4.71%
- WEC Energy Group Inc4.58%
- Ameren Corp4.09%
- NextEra Energy Inc3.86%
- DTE Energy Co3.81%
- CMS Energy Corp3.54%
- NRG Energy Inc3.25%
- Pinnacle West Capital Corp3.15%
- Evergy Inc2.80%
Weight gaps
TMED and UTES share no securities.
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
TMED vs UTES Cost
Overpaying UTES vs TMED
$940
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
TMED 0.44%
$8,852
UTES 0.49%
$9,792
Cost over time
Year by year
| Year | TMED | UTES | Overpaying |
|---|---|---|---|
| 10 | $794 | $883 | $89 |
| 20 | $3,061 | $3,394 | $333 |
| 30 | $8,852 | $9,792 | $940 |
- 0.44%TMED, cheaper
- 0.49%UTES
- Middle half of US Active Sector funds
- Median 0.61%
TMED 7th cheapest of 35 funds
UTES 8th cheapest of 35 funds
TMED vs UTES Dividends
- TMED
- UTES 1.60%
- TMED
- UTES $1.23
- TMED $0.16
- UTES $0.26
- TMED Dec 23, 2025
- UTES Sep 21, 2026
- TMED Dec 26, 2025
- UTES Sep 28, 2026
- TMED Irregular
- UTES Quarterly
Distribution history
TMED vs UTES Risk
Fall from peak · 5 years
Risk facts
- Volatility
- TMED 14.7%UTES 20.0%
- Return per unit of risk
- TMED 1.50UTES 0.96
- Worst fall
- TMED −11.1%UTES −20.4%
- Market sensitivity
- TMED 0.46UTES 0.74
TMED and UTES in the news
Popular comparisons
- 0.44% · 0.17%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.49% · 0.17%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.44% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.49% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.44% · 0.14%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.49% · 0.14%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.


